REPEVAX, suspension for injection, in pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content)
- Licence status
- Active substances
- Tetanus toxoid, Diphtheria toxoid, Pertussis toxoid, Filamentous haemagglutinin, Pertactin, Polio virus type 1 inactivated, Polio virus type 2 inactivated, Polio virus type 3 inactivated, Adsorbed aluminium phosphate, Adsorbed fimbriae types 2 + 3
- Dosage Form
- Suspension for injection in pre-filled syringe
- Licence number
- PA23458/004/001
- Licence holder
- Sanofi Winthrop Industrie
Product documents
Licence information
- ATC code
- J07CA Bacterial and viral vaccines, combined, J07CA02 diphtheria-pertussis-poliomyelitis-tetanus
- Route of supply
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Batches marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.1 of Directive 2001/83/EC, as amended.
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 25/07/2003
Stay updated: document advice
The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie